a place fir glp.1 and eating disprders 504: Adult Disorders in the GLP-1 Era Can You Stop Taking GLP‑1
Description
NIT-1 cells treated with PA+Ex-4 and PA+GW showed enhanced GSIS capacity, increased PPAR expression, decreased UCP2 expression and ADP/ATP ratio, and improved mitochondrial DNA content and mitochondrial membrane potential compared with those treated with PA alone, whereas the opposite results were observed in the PA+GSK group

GLP-1
Learn how this medical weight management option may work for you.

Over 18 months, the condition occurred in approximately 8 cases per 10,000 GLP-1 users, compared with 4 to 6 cases among comparison groups

Han var med til at opdage GLP-1 tilbage i 1980erne, og i denne bog flger vi i de forskningshistoriske fodspor i jagten p det hormon, som i dag betegner et paradigmeskifte i behandlingen af diabetes og svr overvgt.
